Risk of urolithiasis due to topiramate as weight loss drug. International Journal of Biomedical Research, [S. l.], v. 10, n. 1, p. e5031, 2019. DOI: 10.7439/ijbr.v10i1.5031. Disponível em: https://ssjournals.co.in/index.php/ijbr/article/view/5031. Acesso em: 29 mar. 2026.